Literature DB >> 11124472

Perinephric xanthogranulomatosis: CT diagnosis and confirmation by CT-guided percutaneous biopsy.

M Scheer1, M Hon, A A Fruauff, W Blumenfeld, Z D Grossman, D S Katz.   

Abstract

Xanthogranulomatosis is an idiopathic, rare process in which lipid-laden histiocytes may deposit in various locations in the body, which if systemic is called Erdheim-Chester disease. A rare case of isolated retroperitoneal, bilateral perinephric xanthogranulomatosis is reported. The diagnosis was suspected on cross-sectional imaging and was confirmed by CT-guided percutaneous core biopsy.

Entities:  

Mesh：

Year:  2000        PMID： 11124472     DOI： 10.1016/s0899-7071(00)00171-6

Source DB:  PubMed          Journal:  Clin Imaging        ISSN： 0899-7071            Impact factor:   1.605


  4 in total

Review 1.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 2.  Abdominal manifestations of histiocytic disorders in adults: imaging perspective.

Authors:  Abhijit Sunnapwar; Christine O Menias; Vijaynadh Ojili; Maria Policarpio Nicolas; Rashmi Katre; Kiran Gangadhar; Arpit Nagar
Journal:  Br J Radiol       Date:  2016-06-22       Impact factor: 3.039

3.  Erdheim-Chester disease in a child with MR imaging showing regression of marrow changes.

Authors:  Chan Uhng Joo; Yang Sim Go; In Hwan Kim; Chul Seong Kim; Sang Yong Lee
Journal:  Skeletal Radiol       Date:  2004-10-08       Impact factor: 2.199

4.  Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation.

Authors:  Moozhan Nikpanah; Lauren Kim; S Mojdeh Mirmomen; Rolf Symons; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-03-19       Impact factor: 5.315
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.